Last updated: 2026-09-14 05:49:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $265,64, with a market capitalization of $640,02B and a P/E ratio of 30,42. Over the past 52 weeks, its price has ranged from $173,33 to $281,07. This page covers its latest market performance, valuation, price trends and company information.
$640,02B | |
$268,03 | |
$281,07 | |
$46,25 | |
$266,35 | |
3,06M | |
7,67M | |
30,42 | |
$281,07 | |
$173,33 | |
1,97% | |
-- |
Johnson & Johnson (JNJ) last closed at $266,35 as of 2026-09-11 23:52:53, unchanged from the previous close of $266,35.
During the latest regular trading session, JNJ traded between $46,25 and $281,07, with a volume of 3,06M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $275,21 to $265,64, representing a decline of 3,48% ($9,57).
The stock traded between $265,25 and $281,07 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 6,00 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 85,7%
JNJ is currently trading at $265,64, placing it 85,7% of the way from its 52-week low of $173,33 to its 52-week high of $281,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.